Stay updated on Nivolumab Combo for Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo for Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo for Uveal Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical trial record for nivolumab plus ipilimumab in previously untreated metastatic uveal melanoma is now displayed, including study details, eligibility criteria, locations, and outcome measures.
    Difference
    50%
    Check dated 2026-11-07T14:47:52.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:22:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T17:24:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T17:09:34.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T18:08:25.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error, replacing the previous study record content with an error screen. As a result, the trial details, locations, and related information are no longer accessible on the page.
    Difference
    18%
    Check dated 2026-09-19T22:07:37.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo for Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo for Uveal Melanoma Clinical Trial page.